| Completed | Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat Submental Fat | Phase 3 | 2021-12-24 |
| Completed | MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL) Glabellar Lines, Lateral Canthal Lines | Phase 3 | 2019-10-23 |
| Unknown | Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX® Glabellar Frown Lines | Phase 4 | 2019-10-17 |
| Completed | A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fa Submental Fat | Phase 2 | 2019-09-10 |
| Unknown | Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder Overactive Bladder | Phase 3 | 2019-08-23 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines Lateral Canthal Lines | Phase 2 | 2019-05-21 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines Glabellar Frown Lines | Phase 2 | 2019-05-20 |
| Completed | Observational Study to Determine the Efficacy and Safety of Potenfill for Temporary Penile Enhancement Penile Enhancement | — | 2019-04-10 |
| Completed | MT10109L in the Treatment of Glabellar Lines Glabellar Lines | Phase 3 | 2018-12-24 |
| Completed | MT10109L in the Treatment of Lateral Canthal Lines Lateral Canthal Lines | Phase 3 | 2018-12-20 |
| Completed | The Efficacy and Safety of Repeat-dose Potenfill for Temporary Penile Enhancement Penile Girth Enhancement, Penile Enhancement | N/A | 2018-12-17 |
| Completed | The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines Glabellar Frown Lines | Phase 3 | 2018-12-13 |
| Completed | MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines Lateral Canthal Lines, Glabellar Lines | Phase 3 | 2018-11-05 |
| Completed | MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Line Glabellar Lines, Lateral Canthal Lines | Phase 3 | 2018-10-26 |
| Completed | Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject Overweight | N/A | 2018-09-04 |
| Completed | Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis Hyperhidrosis Primary Focal Axilla | Phase 3 | 2018-08-03 |
| Completed | Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy Subjects Healthy Volunteers | Phase 1 | 2018-07-31 |
| Completed | Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face Mid Face Volume Loss | N/A | 2018-05-29 |
| Completed | Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers Healthy | Phase 1 | 2018-04-16 |
| Completed | MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy Masseter Muscle Hypertrophy | Phase 3 | 2018-04-09 |
| Completed | Neuramis® Deep Lidocaine Compared to YVOIRE® Volume Plus for Correction of Nasolabial Folds Nasolabial Folds | N/A | 2018-04-02 |
| Completed | Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers Anhidrotic Area, Hyperhidrosis | Phase 1 | 2018-03-20 |
| Completed | Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder Overactive Bladder | Phase 1 | 2017-12-13 |
| Completed | Efficacy and Safety of Potenfill for Temporary Penile Enhancement Penile Enhancement | N/A | 2017-11-16 |
| Completed | CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3) Muscle Spasticity | Phase 3 | 2017-11-13 |
| Completed | Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers Healthy | Phase 1 | 2017-10-12 |
| Completed | MEDITOXIN® in Treatment of Crow's Feet Line Crow's Feet Lines | Phase 3 | 2017-08-17 |
| Completed | CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1) Muscle Spasticity | Phase 1 | 2017-07-17 |
| Completed | Meditoxin® Treatment in Patients With Cervical Dystonia Dystonia, Dystonic Disorder | Phase 3 | 2017-07-06 |
| Completed | Pivotal Clinical Study to Assess the Anti-adhesive Effect and Safety of ABT13107 Applied to Postoperative Intr Postoperative Adhesion of Uterus | N/A | 2017-02-27 |
| Completed | Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines Glabellar Frown Lines | Phase 4 | 2016-12-30 |
| Completed | Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume Aging | N/A | 2016-11-03 |
| Completed | Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity Muscle Spasticity | Phase 4 | 2016-05-30 |
| Completed | Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm Essential Blepharospasm | Phase 3 | 2016-05-25 |
| Completed | Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lin Glabellar Lines | Phase 3 | 2016-03-30 |
| Completed | Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy Hypertrophy of Masseter Muscle | Phase 2 | 2014-10-06 |
| Completed | Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line Glabellar Frown Lines | Phase 3 | 2014-01-01 |
| Completed | MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity Spasticity, Muscle | Phase 4 | 2013-09-06 |
| Completed | Efficacy and Safety Evaluation Study of Neuramis® Deep Lidocaine in Correction of Nasolabial Fold Nasolabial Fold | Phase 3 | 2013-06-01 |
| Completed | Efficacy and Safety of MEDITOXIN® in Cervical Dystonia Cervical Dystonia | Phase 3 | 2013-01-09 |
| Completed | Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX® Healthy Volunteers | Phase 1 | 2012-09-01 |
| Completed | Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dy Cervical Dystonia | Phase 2 | 2012-08-01 |
| Completed | Efficacy and Safety Study of Neuramis in Correction of Nasolabial Fold Nasolabial Fold | Phase 3 | 2012-02-09 |
| Completed | Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines Glabellar Frown Lines | Phase 2 | 2011-12-07 |
| Completed | Efficacy and Safety Study of MT10109L in the Treatment of Glabella Line(Including a Preliminary Study to Evalu Glabella Line Severity | Phase 2 / Phase 3 | 2011-12-01 |
| Completed | MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity Spasticity | Phase 3 | 2011-03-01 |
| Completed | Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm Essential Blepharospasm | Phase 4 | 2010-08-01 |
| Completed | The Efficacy and Safety of MEDITOXIN® in Children With Cerebral Palsy Muscle Spasticity | Phase 4 | 2010-08-01 |
| Completed | Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines Skin Aging | Phase 3 | 2009-11-23 |